According to the new market research report “Cell Harvesting Market by Type (Manual, Automated), Application (Biopharmaceutical, Stem Cell Research), End User (Biotechnology, Biopharmaceutical Companies, Research Institute), and Region (North America, Europe, APAC, Row) – Global Forecast” published by MarketsandMarkets™.
Revenue Growth Opportunities and Growth Drivers?
Cell harvesting is the process of harvesting cells from the culture media during upstream and downstream bioprocessing. Cell harvesters are used extensively for the cell harvesting process and are compatible with a wide range of assays.
The Cell Harvesting Market is expected to grow at a CAGR of 8.7% during the forecast period to reach USD 324.5 Million.
Growth Boosting Factors:
- Rising Investments in Regenerative Medicine and Cell-Based Research
- Growth of the Biotechnology and Biopharmaceutical Industry
- Increasing Incidence of Chronic and Infectious Diseases
- Growth Opportunities in Emerging Economies
Browse 67 market data Tables and 27 Figures spread through 101 Pages and in-depth TOC – Request Research Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=209513544
Market Segmentation in Depth:
On the basis of type, the market is segmented into manual and automated cell harvesters. In 2017, the manual cell harvesters segment accounted for the largest share of this market. The high share of the manual harvesters segment can be attributed to their ease of use and low price as compared to automated harvesters.
In the end user, the cell harvesting market is segmented into research institutes, biotechnology & biopharmaceutical companies, and other end users. The biotechnology & biopharmaceutical companies segment accounted for the largest share of the cell harvesters market. The high share of this segment can be attributed to the high prevalence of chronic diseases. Biotechnology & biopharmaceutical companies conduct R&D activities to develop new products for the treatment of these diseases.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=209513544
Some key players mentioned in the research report are:
PerkinElmer (US), Brandel (US), TOMTEC (US), Cox Scientific (UK), Connectorate (Switzerland), Scinomix (US), ADSTEC (Japan), and Terumo BCT (a part of Terumo Corporation) (Japan).
Worldwide Geographical Segmentation in-detailed:
By region, the cell harvesting market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). The market is dominated by North America, followed by Europe; however, the APAC region is expected to witness the highest growth rate during the forecast period. Increasing private and government funding for stem cell research in this region and growing expansion of key market players in emerging Asian countries are some of the factors driving the APAC market.
Cell harvesting is the process of harvesting cells from the culture media during upstream and downstream bioprocessing.
Cell harvesters are used extensively for the cell harvesting process and are compatible with a wide range of assays, including cell proliferation assays, receptor binding assays, and adherent cell assays.According to the new market research report “Cell Harvesting Market by Type (Manual, Automated), Application (Biopharmaceutical, Stem Cell Research), End User (Biotechnology, Biopharmaceutical Companies, Research Institute), and Region (North America, Europe, APAC, Row) – Global Forecast” published by MarketsandMarkets™, is expected to grow at a CAGR of 8.7% during the forecast period to reach USD 324.5 Million.Growth Drivers in Depth:Rising Investments in Regenerative Medicine and Cell-Based ResearchGrowth of the Biotechnology and Biopharmaceutical IndustryIncreasing Incidence of Chronic and Infectious DiseasesGrowth Opportunities in Emerging EconomiesRequest Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=209513544The manual cell harvesters segment dominated the marketOn the basis of type, segmented into manual and automated cell harvesters.
The manual cell harvesters segment accounted for the largest share of this market.
The high share of the manual harvesters segment can be attributed to their ease of use and low price as compared to automated harvesters.The biotechnology & biopharmaceutical companies segment dominated the Cell Harvesting MarketIn the end user, segmented into research institutes, biotechnology & biopharmaceutical companies, and other end users.
The biotechnology & biopharmaceutical companies segment accounted for the largest share of the cell harvesters market.
The high share of this segment can be attributed to the high prevalence of chronic diseases.
http://www.lovelacebiomedical.org/services/biotechnology-lab/Lovelace has a pioneer biotechnology testing lab in the USA and we have huge experience in biotechnology to perform all your biotechnology research.
This report aims to provide detailed insights into the NGS-based RNA-sequencing market.
It provides valuable information on the type, procedure, application, and region in the market.
Expected Revenue Growth: The NGS-based RNA-sequencing industry size is projected to reach USD 4.2 billion by 2024 from USD 1.7 billion in 2019, at a CAGR of 20.0% during the forecast period.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=102977816 Key Factors Driving Market Growth: Market growth is driven mainly by the advantages of RNA-seq over conventional technologies; an increasing number of RNA-seq grants; rising number of research activities involving RNA-seq; and rapid growth in precision medicine market.
The expression profiling analysis segment accounted for the largest share of the NGS-based RNA-sequencing industry, by application, in 2018 Based on application, the NGS-Based RNA-Sequencing Market is segmented into expression profiling analysis, small RNA sequencing, De Novo transcriptome assembly, and variant calling & transcriptome epigenetics.
Nanopore sequencing technology registers the highest growth rate in the market as it is the only sequencing technology with direct RNA sequencing capabilities and facilitates sequencing of full-length RNA strands and modified RNA nucleotides using a simple library prep, without the need of conversion to double-stranded DNA.
